Abstract
Genistein is an isoflavonic phyto-oestrogen contained in soya beans. It is thought to display anti-cancer effects. This study was designed to investigate its effect on human intestinal colon cancer Caco-2 cells. MTT assay, flow cytometric analysis and western blotting were used to investigate the effect of genistein on cell proliferation, cell cycle progression and protein alterations of selected cell cycle-related proteins in Caco-2 cells. Our results showed that genistein and daidzein significantly suppressed cell proliferation. Genistein treatment was demonstrated to modulate cell cycle distribution through accumulation of cells at G2/M phase, with a significant decreasing effect of Cyclin B1 and Serine/threonine-protein kinase 2 (Chk2) proteins expression. However, daidzein did not alter the cell cycle progression in Caco-2 cells. All these observation strongly indicate that genistein has anti-proliferative effect in human intestinal colon cancer Caco-2 cells through the down-regulation of cell cycle check point proteins, Cyclin B1 and Chk2.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baselga J (2001) Targeting the epidermal growth factor receptor: a clinical reality. J Clin Oncol 19:41–44
Bocca C, Bozzo F, Gabriel L, Miglietta A (2007) Conjugated linoleic acid inhibits Caco-2 cell growth via ERK-MAPK signaling pathway. J Nutri Biochem 18:332–340
Chang KL, Kung ML, Chow NH, Su SJ (2004) Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and wee1. Biochem Pharmacol 67:717–726
Chiechi LM (1999) Dietary phytoestrogens in the prevention of long-term postmenopausal diseases. Intl J Gynaecol Obstet 67:39–40
Croisy-Delcey M, Croisy A, Mousset S, Letourneur M, Bisagni E, Jacquemin-Sablon A, Pierre J (1997) Genistein analogues: effects on epidermal growth factor receptor tyrosine kinase and on stress-activated pathways. Biomed Pharmacother 51:286–294
Devesa LL, Silverman DT, Yough JL (1987) Cancer incidence and mortality trends among whites in the United States, 1947–1984. J Natl Cancer Inst 79:701–708
Gavet O, Pines J (2010) Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell 18:533–543
Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824–1827
Hurwitz H, Kabbinavar F (2005) Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer. Oncology 69:17–24
Ismail IA, Kang KS, Kim JW, Sohn YK (2006) Genistein induces G2/M cell cycle arrest and apoptosis in rat neuroblastoma B35 cells; involvement of p21waf1/cip1, Bax and Bcl-2. Korean J Pathol 40:339–347
Ismail IA, Kang KS, Lee HA, Kim JW, Sohn YK (2007) Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation. Eur J Pharmacol 575:12–20
Jiang L, Jiang LS, Yan LN, Li FY, Wang W, Cheng NS, Wen TF (2010) Effects of epidermal growth factor receptor inhibitor genistein on proliferative cholangitis in rats. J Surg Res 162:59–67
Kakino S, Sasaki K, Kurose A, Ito H (1996) Intracellular localization of cyclin B1 during the cell cycle in glioma cells. Cytometry 24:49–54
Kallay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS (2002) Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 40:1191–1196
Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316–323
Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics, 1999. CA Cancer J Clin 49:8–31
Lindqvist A, Rodriguez-Bravo V, Medema RH (2009) The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 185:193–202
Mansour A, McCarthy B, Schwander SK, Chang V, Kotenko S, Donepudi S, Lee J, Raveche E (2004) Genistein induces G2 arrest in malignant B cells by decreasing IL-10 secretion. Cell Cycle 3:1597–1605
Messina MJ, Persky V, Kenneth KDR, Setchell DR, Bames S (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21:1l3–l31
Mutanen M, Pajari AM, Oikarinen SI (2000) Beef induces and rye bran prevents the formation of intestinal polyps in Apc (Min) mice: relation to β-catenin and PKC isozymes. Carcinogenesis 21:1167–1173
Niida H, Nakanishi M (2005) DNA damage checkpoints in mammals. Mutagenesis 21:3–9
Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics, 1997. CA Cancer J Clin 47:5–27
Ross JA, Kasum CM (2002) Dietary flavonoids: bioavailability, metabolic effects, and safety. Ann Rev Nutr 22:19–34
Schmidt S, Michna H, Diel P (2005) Combinatory effects of phytoestrogens and 17β-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 94:445–449
Shen JC, Klein RD, Wei Q, Guan Y, Contois JH, Wang TT, Chang S, Hursting SD (2000) Low-dose genistein induces cyclin-dependent kinase inhibitors and G (1) cell-cycle arrest in human prostate cancer cells. Mol Carcinog 29:92–102
Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 10:768–780
Wang HZ, Zhang Y, Xie LP, Yu XY, Zhang RO (2002) Effects of genistein and daidzein on the cell growth, cell cycle, and differentiation of human and murine melanoma cells. J Nutri Biochem 13:421–426
Wolter F, Turchanowa L, Stein J (2003) Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis 24:469–474
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Han, J., Kurita, Y. & Isoda, H. Genistein-induced G2/M cell cycle arrest of human intestinal colon cancer Caco-2 cells is associated with Cyclin B1 and Chk2 down-regulation. Cytotechnology 65, 973–978 (2013). https://doi.org/10.1007/s10616-013-9592-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-013-9592-0